Skip to content

Alpha Ketoanalogue

Overview

Medical Information

Dosage Information

Side Effects

Safety Information

Reference Information

Frequently Asked Questions

What is the recommended dosage for Alpha Ketoanalogue?

For adults (70kg), 4-8 tablets three times daily with meals. Dosage is adjusted based on body weight (approximately 1 tablet/5kg body weight/day) and should be individualized based on renal function and dietary protein intake.

What are the common side effects?

Hypercalcemia, nausea, vomiting, diarrhea, abdominal discomfort, and metallic taste.

Who should not take Alpha Ketoanalogue?

Patients with hypercalcemia, disturbed amino acid metabolism, or hypersensitivity to any component of the drug. Patients with hereditary phenylketonuria should also avoid this drug.

What are the significant drug interactions?

Calcium supplements, drugs forming insoluble complexes with calcium (e.g., tetracyclines, quinolones), iron, fluoride, estramustine, and aluminum hydroxide. Alcohol should be avoided.

How does Alpha Ketoanalogue work?

It provides essential amino acids without adding to the nitrogen load on the kidneys, thereby reducing the buildup of uremic toxins.

Can Alpha Ketoanalogue be used during pregnancy or breastfeeding?

Safety and efficacy have not been established. Use only if the benefits outweigh the risks.

What is the importance of a protein-restricted diet when using Alpha Ketoanalogue?

A protein-restricted diet is crucial to minimize nitrogenous waste buildup, maximizing the therapeutic benefit of Alpha Ketoanalogue.

How long should Alpha Ketoanalogue treatment continue?

Treatment is usually continued as long as GFR is below 25 ml/min and the patient is on a protein-restricted diet.

What monitoring is required for patients on Alpha Ketoanalogue?

Regular monitoring of serum calcium, phosphate, and other renal function parameters is recommended.

Are there any special considerations for elderly patients?

Dose adjustments may be required based on renal function in elderly patients.